Gestational diabetes mellitus (GDM) decreases butyrylcholinesterase (BChE) activity and changes its relationship with lipids

Genetics and Molecular Biology

Volumn 37, Issue 1, 2014, Pages 1-6

  Guimarães, Larissa O ^a   De Andrade, Fabiana A ^a   Bono, Gleyse F ^a   Setoguchi, Thaís E ^a   Brandão, Mariana B ^a   Chautard Freire Maia, Eleidi A ^a   Dos Santos, Izabella C R ^a   Picheth, Geraldo ^a   Faria, Ana Cristina R de A ^a   Réa, Rosângela R ^a   Souza, Ricardo L R ^a   Furtado Alle, Lupe ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

116a variant; 1615a variant; Butyrylcholinesterase (BChE); Gestational diabetes mellitus

Indexed keywords

CHOLINESTERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BCHE GENE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; HAPLOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84897134815     PISSN: 14154757     EISSN: 16784685     Source Type: Journal    
DOI: 10.1590/S1415-47572014000100003     Document Type: Article

References (44)

1. Abbott CA, Mackness MI, Kumar S, Olukoga OA, Gordon C and Arrol S (1993) Relationship between serum butyrylcholi nesterase activity, hypertriglyceridemia in insulin sensitivity in diabetes. Clin Sci 85:77-81.
2. Alcântara VM, Chautard-Freire-Maia EA, Scartezini M, Cerci MS, Braun-Prado K and Picheth G (2002) Butyrylcho linesterase activity and risk factors for coronary artery disease. Scand J Clin Lab Invest 62:399-404.
3. Alcântara VM, Oliveira LC, Réa RR, Suplicy HL and Chautard Freire-Maia EA (2003) Butyrylcholinesterase activity and metabolic syndrome in obese patients. Int J Obes Relat Metab Disord 27:1557-1564.
4. Alcântara VM, Oliveira LC, Réa RR, Suplicy HL and Chautard-Freire-Maia EA (2005) Butyrylcholinesterase activity and metabolic syndrome in obese patients. Clin Chem Lab Med 43:285-288.
5. Altamirano CV, Bartels CF and Lockridge O (2000) The butyryl cholinesterase K-variant shows similar cellular protein turn over and quaternary interaction to the wild type enzyme. J Neurochem 74:869-877.
6. American Diabetes Association (2004) Diagnosis and classification of diabetes mellitus. Diabetes Care 27:5-10.
7. Antopol W, Tuchman L and Schifrin A (1937) Cholinesterase activity of human sera with special reference to hyperthyroidism. Proc Soc Exp Biol Med 36:4650.
8. Babaoglu MO, Ocal T, Bayar B, Kayaalp SO and Bozkurt A (2004) Frequency and enzyme activity of the butyrylcholi nesterase K-variant in a Turkish population. Eur J Clin Pharmacol 59:875-877.
9. Bartels CF, Van Der Spek AFL and La Du BN (1990) Two polymorphisms in the noncoding regions of the BCHE gene. Nucleic Acids Res 18:6171.
10. Blitt CD, Petty WC, Alberternst EE and Wright BJ (1977) Correlation of plasma cholinesterase activity and duration of action of succinylcholine during pregnancy. Anesth Analg 56:78-83.
11. Buchanan TA and Xiang AH (2005) Gestational diabetes mellitus. J Clin Invest 115:485-491.
12. Carpenter MW and Coustan DR (1982) Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 144:768-773.
13. Chatonnet A and Lockridge O (1989) Comparison of butyrylcho linesterase and acetylcholinesterase. Biochem J 260:625-634.
14. Das UN (2007) Acetylcholinesterase and butyrylcholinesterase as possible markers of low-grade systemic inflammation. Med Sci Monit 13:RA214-221.
15. Dietz AA, Ribinstein HM, Lubrano T and Hodges LK (1972) Improved method for the differentiation of cholinesterase variants. Am J Genet 24:58-64.
16. Evans RT and Wroe J (1978) Is serum cholinesterase activity a predictor of succinyl choline sensitivity? An assessment of four methods. Clin Chem 24:1762-1766.
17. Evans RT and Wroe J (1980) Plasma cholinesterase changes during pregnancy. Their interpretation as a cause of suxame-thonium-induced apnoea. Anaesthesia 35:651-654.
18. Furtado-Alle L, Andrade FA, Nunes K, Mikami LR, Souza RLR and Chautard-Freire-Maia EA (2008) Association of variants of the-116 site of the butyrylcholinesterase BCHE gene to enzyme activity and body mass index. Chem Biol Int 175:115-118.
19. Hashim Y, Shepherd D, Wiltshire S, Holman RR, Levy JC, Clark A and Cull CA (2001) Butyrylcholinesterase K variant on chromosome 3q is associated with type II diabetes in white Caucasian subjects. Diabetologia 44:2227-2230.
20. Howard JK, East NJ and Chaney JL (1978) Plasma cholinesterase activity in early pregnancy. Arch Environ Health 33:277-279.
21. Iwasaki T, Yoneda M, Nakajima A and Terauchi Y (2007) Serum butyrylcholinesterase is strongly associated with adiposity, the serum lipid profile and insulin resistance. Intern Med 46:1633-1639.
22. Lahiri DK and Nurnberger Jr JL (1991) A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19:5444.
23. Lepienski LM, Souza RLR, Chautard-Freire-Maia EA, Alcântara VM and Réa RR (2006) Variant K of butyrylcholinesterase and risk of early-onset type 1 diabetes mellitus in Euro Brazilians. Diabetes Obes Metab 8:709-711.
24. Mahmoud FF, Haines DD, Abul HT, Omu AE and Abu-Donia MB (2006) Butyrylcholinesterase activity in gestational diabetes: Correlation with lymphocyte subpopulations in peripheral blood. Am J Reprod Immunol 56:185-192.
25. Omu AE, Al-Azemi MK, Omu FE, Fatinikun T, Abraham S, George S and Mahnazhath N (2010) Butyrylcholinesterase activity in women with diabetes mellitus in pregnancy: Correlation with antioxidant activity. J Obstet Gynaecol 30:122-126.
26. Orhan H, Onderoglu L, Yücel A and Sahin G (2003) Circulating biomarkers of oxidative stress in complicated pregnancies. Arch Gynecol Obstet 267:189-195.
27. Pavkovic E, Simon V, Reiner E, Sucic M and Lipovac V (1993) Serum paraoxonase and cholinesterase activities in individuals with lipid and glucose metabolism disorders. Chem Biol Interact 87:179-182.
28. Ramkumar KM, Latha M, Ashokkumar N, Pari L and Ananthan R (2005) Modulation of impaired cholinesterase activity in experimental diabetes: Effect of Gymnema montanum leaf extract. J Basic Clin Physiol Pharmacol 16:17-35.
29. Randell EW, Mathews MS, Zhang H, Seraj JS and Sun G (2005) Relationship between serum butyrylcholinesterase and the metabolic syndrome. Clin Biochem 38:799-805.
30. Robitaille J and Grant A (2008) The genetics of gestational diabetes mellitus: Evidence for relationship with type 2 diabetes mellitus. Genet Med 10:240-250.
31. Schmidt MI, Duncan BB, Reichelt AJ, Branchtein L, Matos MC, E Forti AC, Spichler ER, Pousada JMDC, Teixeira MM and Yamashita T (2001) Gestational diabetes mellitus diagnosed with a 2 h 75 g oral glucose tolerance test and adverse pregnancy outcomes. Diabetes Care 24:1151-1155.
32. Schneider S, Roessli DE and Excoffier L (2000) A software for population genetics data analysis. Genetics and Biometry Laboratory, University of Geneva, Switzerland, Arlequin ver. 2.000.
33. Sham PC and Curtis D (1995) Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 59:97-105.
34. Siqueira MEPB, Fernícola NAGG and Borges EL (1978) Determinação de níveis normais de colinesterase plasmática e eritrocitária. Rev Saúde Públ 12:340-344.
35. Soreq H, Zamir R, Zevin-Sonkin D and Zakut H (1987) Human cholinesterase genes localized by hybridization to chromosomes 3 and 16. Hum Genet 77:325-328.
36. Souza RLR, Castro RMV, Freund A, Culpi L and Chautard-Freire-Maia EA (1998) Frequencies of the butyrylcholinesterase K mutation in Brazilian populations of European and African origin. Hum Biol 70:965-970.
37. Tham E, Liu J, Innis S, Thompson D, Gaylinn BD, Bogarin R, Haim A, Thorner MO and Chanoine JP (2009) Acylated ghrelin concentrations are markedly decreased during pregnancy in mothers with and without gestational diabetes: Relationship with cholinesterase. Am J Physiol Endocrinol Metab 296:E1093-E1100.
38. Vaisi-Raygani A, Rahimi Z, Entezami H, Kharrazi H, Bahrhemand F, Tavilani H, Rezaei M, Kiani A, Nomanpour B and Pourmotabbed T (2008) Butyrylcholinesterase K variants increase the risk of coronary artery disease in the population of western Iran. Scand J Clin Lab Invest 68:123-129.
39. Valle A, O'Connor DT, Taylor P, Zhu G, Montgomery GW, Slagboom PE, Martin NG and Whitfield JB (2006) Butyrylcholinesterase: Association with the metabolic syndrome and identification of 2 gene loci affecting activity. Clin Chem 52:1014-1020.
40. Whittaker M (1980) Plasma cholinesterase variants and the anaesthetist. Anesthesia 35:174-197.
41. Whittaker M (1986) Cholinesterase. Karger, Basel, New York, pp 65-74.
42. World Health Organization (1999) Report of a WHO Consultation: Aiagnosis and classification of diabetes mellitus and its complications. Department of Noncommunicable Disease Surveillance, Geneva.
43. World Health Organization (2006) Guidelines for the prevention, management and care of diabetes mellitus. EMRO Techn Publ Ser 32:1-82.
44. Wyse AT, Stefanello FM, Chiarani F, Delwing D, Wannmacher CM and Wajner M (2004) Arginine administration decreases cerebral cortex acetylcholinesterase and serum butyrylcholinesterase probably by oxidative stress induction. Neurochem Res 29:385-389.